Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder.
Aust S, Gärtner M, Basso L, Otte C, Wingenfeld K, Chae WR, Heuser-Collier I, Regen F, Cosma NC, van Hall F, Grimm S, Bajbouj M.
Aust S, et al. Among authors: regen f.
Eur Neuropsychopharmacol. 2019 Apr;29(4):529-538. doi: 10.1016/j.euroneuro.2019.02.005. Epub 2019 Feb 13.
Eur Neuropsychopharmacol. 2019.
PMID: 30772118
Clinical Trial.